Patient Profiles
Benefits for Your Patients With Once-Yearly VANTAS®
VANTAS may help patients who are on extended GnRH agonist therapy for the palliative treatment of advanced prostate cancer. VANTAS may also help provide patients with flexibility and control as they manage their lives. Four profiles of patients who may benefit from treatment with VANTAS can be accessed below. Click on the profile(s) that interest(s) you.
Fred, Age 69, High School Teacher
Fred is on extended GnRH agonist therapy and has an active lifestyle that includes traveling. He hopes that his course of treatment with VANTAS will fit well with his busy schedule.
John, Age 71, Small Business Owner
John is a businessman with ongoing career demands who has trouble keeping his scheduled doctor appointments. John aspires to effectively manage his advanced prostate cancer regardless of his erratic schedule.
José, Age 73, Retiree on Disability
José is a patient with multiple comorbidities that require many doctor appointments. For José, VANTAS can help reduce the total number of doctor visits for his administration of GnRH agonist therapy.
George, Age 78, Retired Military
George is confined to a wheelchair and poorly tolerates intramuscular injections due to minimal buttock muscle. For George, once-yearly VANTAS provides symptom control.
All patients are hypothetical patients; individual results may vary.
